Mice lacking DIX domain containing-1 (DIXDC1), an intracellular Wnt/β-catenin signal pathway protein, have abnormal measures of anxiety, depression and social behavior. Pyramidal neurons in these animals' brains have reduced dendritic spines and glutamatergic synapses. Treatment with lithium or a glycogen synthase kinase-3 (GSK3) inhibitor corrects behavioral and neurodevelopmental phenotypes in these animals. Analysis of DIXDC1 in over 9000 cases of autism, bipolar disorder and schizophrenia reveals higher rates of rare inherited sequence-disrupting single-nucleotide variants (SNVs) in these individuals compared with psychiatrically unaffected controls. Many of these SNVs alter Wnt/β-catenin signaling activity of the neurally predominant DIXDC1 isoform; a subset that hyperactivate this pathway cause dominant neurodevelopmental effects. We propose that rare missense SNVs in DIXDC1 contribute to psychiatric pathogenesis by reducing spine and glutamatergic synapse density downstream of GSK3 in the Wnt/β-catenin pathway.
INTRODUCTION
Advances in human genomics are revolutionizing knowledge of molecules conferring susceptibility to psychiatric disorders, but have simultaneously highlighted the complexity of genetic contributions and underscored a need to define common biological pathways. 1, 2 One pathway proposed to have a role based on such evidence is Wnt/β-catenin signaling, a biochemical cascade conserved in all metazoans by which nearby cells communicate during and after development. 3, 4 DIX domain containing-1 (DIXDC1), a positive cytoplasmic transducer of the Wnt/β-catenin pathway, 5, 6 is of additional interest because it interacts with DISC1 (disrupted in schizophrenia 1), a gene separately implicated in the genetics of psychiatric disorders including schizophrenia (Scz), major depression, bipolar disorder (BD) and autism spectrum disorder (ASD). 7, 8 Compared with some core Wnt/β-catenin pathway components, DIXDC1 has a relatively restricted tissue distribution including in the late developmental and postnatal central nervous system, 6, 9 suggesting that it might have specialized roles in neurons and that its functional sequence variants might manifest as behavioral syndromes in the human population.
Here we describe a multifaceted analysis of DIXDC1 in neurodevelopment and psychopathogenesis. Using behavioral, neurodevelopmental, biochemical and pharmacological analyses of a knockout mouse model combined with human genetic analyses across several psychiatric disorders and functional analyses of rare missense mutations found in one set of such patients (ASD), we show that DIXDC1 participates in the regulation of dendritic spine and glutamatergic synapse density downstream of Wnt/β-catenin signaling and upstream of behavior, particularly depression-and anxiety-like behaviors potentially relevant to affective disorders and reciprocal social interactions potentially relevant to ASD.
MATERIALS AND METHODS Animals
The Dixdc1 knockout (Dixdc1KO) mouse line was created by gene targeting that replaced several critical exons of the Dixdc1 locus with a neo interrupter cassette, causing loss of Dixdc1 gene products confirmed at both the mRNA 10 and protein levels ( Supplementary Figure 1a) . Products of the original gene-targeting event were outcrossed 410 times to
RESULTS

Depression, anxiety and social behavior in Dixdc1KO mice
We showed previously that homozygous Dixdc1KO mice maintained in an isogenic C57Bl/6 background had behavioral differences potentially relevant to psychiatry, but were also generally hypoactive. 10 Neurodevelopmental and behavioral phenotypes in mice can be sensitive to isogenic background and this has occasionally confounded interpretation. [11] [12] [13] Accordingly, we reprobed Dixdc1KO mice for behavioral and neurodevelopmental phenotypes that remained robust even in a mixed outbred (primarily CD-1) genetic background and used these mice for all behavioral and neurodevelopmental phenotyping in this study. Outbred Dixdc1KO mice were no different from WT littermates in general activity or several other behavioral measures ( Supplementary Table 1 ), yet had decreased latency to immobility (Figure 1a , left) and spent more total time immobile ( Figure 1a , right) in the forced swim test (FST), an assay for behavioral despair regarded as a rodent model for depression. 14 These mice also had a trend toward increased total time immobile in the tail suspension test, an independent assay for behavioral despair (Supplementary Figure 2) . Homozygous Dixdc1KO mice also spent less time than WT littermates in the center versus surround of an open field (Figure 1b ), an indication of increased anxiety. 15 Furthermore, in the hyponeophagia assay, which measures balance between opposing drives to feed versus to avoid the unfamiliar, 16 Dixdc1KO mice had an increased latency to begin feeding (Figure 1c , left) and spent less total time feeding (Figure 1c , right).
In the social interactions in pairs (SIP) test, where two males of the same genotype freely interact within a closed arena, 17 Dixdc1KO mice spent less time together than WT littermates (Figure 1d , left). Interestingly, this decrease in total interaction time was not attributable to a reduced number of mouse-mouse interactions. Instead Dixdc1KO mice spent less time on average during each interaction (Figure 1d , middle) and their longest interaction was shorter (Figure 1d , right). Interactions of longer duration in this assay were characterized by reciprocal social behavior including nose-to-nose sniffing, nose-to-anogenital sniffing or one animal following close behind the other, suggesting that reciprocal social interactions are deficient in this mouse model. Pyramidal neurons in Dixdc1KO mice have reduced spines and glutamatergic synapses Dixdc1KO mice are viable and fertile and have grossly normal brains with typical regional architecture 10 (Supplementary Figures 1b-h). We therefore searched for other neuronal phenotypes underlying behavioral differences in these animals. Studies of other neurodevelopmentally expressed Wnt pathway components and DISC1 have supported roles in dendrite, dendritic spine and glutamatergic synapse formation and function. [18] [19] [20] [21] [22] To initially probe for these phenotypes in the Dixdc1KO mouse line, we used cultured hippocampal neurons because of their established validity for modeling these aspects of neurodevelopment. 22 Both visual inspection and Sholl analysis 23 revealed no significant differences in dendrite arborization in neurons from Dixdc1KO neonates in the mixed outbred genetic background ( Supplementary Figures 3a-c) ; however, mutant neurons had significantly reduced spine density along primary dendrites (Figures 1e and f) and a significantly increased percentage of immature (filopodial) spines (Figures 1e and g). We confirmed these same spine phenotypes within forebrain cortical tissue by crossing in transgenic Thy1-GFP alleles that sparsely label deep layer (L5/6) pyramidal neurons, 24 then collecting tissue and quantifying density and maturity of spines along apical dendrites of individual GFP-expressing neurons; 18 here again Dixdc1KO mutants had reduced spine density and an increased percentage of filopodial spines (Figures 1h-j ). In the living brain, we imaged apical dendrites and spines in 1-month-old transgenic Thy1-YFP mice using transcranial two-photon imaging, once more finding that spine density on L5 apical dendrites in the somatosensory cortex was reduced in the Dixdc1KO (Figures 1k and l) . Interestingly, spine dynamics (proportion of spines formed and eliminated over 7 days) were no different between Dixdc1KO and WT littermates at this stage ( Figure 1m ). To substantiate imaging findings at the level of neuronal function, we conducted internal electrophysiological recordings from L5/6 corticothalamic pyramidal neurons in the prefrontal cortex. In Dixdc1KO mice these neurons had a reduced hyperpolarization-activated cationic current (h-current; I h ) as estimated from the reduction in voltage 'sag' and rebound after-depolarization in response to a hyperpolarizing current pulse (Figures 1n and o) . We confirmed this by directly measuring I h current in response to hyperpolarizing voltage steps: this current was reduced in Dixdc1KO L5/6 corticothalamic pyramidal neurons and inhibited by the I h channel blocker ZD7288 (Figures 1p and q) . The I h current is mediated by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels localized primarily to mature spines. 25 We therefore corroborated the electrophysiological finding of reduced Ih current via the methodologically independent strategy of fluorescent immunohistochemistry, visualizing the HCN1 channel protein using a specific antibody and counting puncta along dendrites of GFP-expressing L5/6 pyramidal neurons in Thy1-GFP mice. This method confirmed a significant reduction in HCN1 puncta on Dixdc1KO L5/6 pyramidal neuron dendrites (Figures 1r and s). In sum, the electrophysiological and immunohistochemical data agree and strongly support our other measures of reduced mature spine density in these animals.
Spines correspond to the postsynaptic compartment of most glutamatergic inputs to pyramidal neuron dendrites. 26 We therefore asked whether spine deficits in Dixdc1KO pyramidal neurons were accompanied by deficits in glutamatergic synapse density. Cultured neurons from Dixdc1KO neonates had reduced glutamatergic synapse density along dendrites as measured by fluorescent confocal colocalization of pre-and postsynaptic molecular markers (Figures 1t and u). We confirmed this within cortical tissue, observing a deficit in glutamatergic synapse density along apical dendrites of individual pyramidal neurons in Thy1-GFP Dixdc1KO mice (Figures 1v and w) . In contrast, using similar methodologies we detected no differences in GABAergic synapse density ( Supplementary Figures 3d-g ).
Neurons from Dixdc1KO mice have impaired Wnt/β-catenin signal transduction
Given that Dixdc1 has a conserved subdomain that directly interacts with the core Wnt/β-catenin pathway components Dvl and Axin, 5, 6, 27, 28 we hypothesized that Wnt/β-catenin signal transduction would be impaired at the level of these cytoplasmic signal-transduction proteins in differentiating Dixdc1KO pyramidal neurons. We tested this via several complementary approaches: first, we tested whether Wnt/β-catenin signal pathway activity was altered in developing neurons of Dixdc1KO mice by directly measuring the levels of β-catenin unphosphorylated at residue S33 ('active β-catenin'), the molecular target of glycogen synthase kinase-3 (GSK3) in the Wnt/β-catenin pathway. There was no difference in levels of active β-catenin in unstimulated Dixdc1KO versus WT cultured forebrain neurons (Figures 2a and b ). However, treatment of these neurons with Wnt3a, an extracellular activator of this pathway, 29 resulted in markedly different responses in Dixdc1KO versus WT neurons: in WT neurons the level of active β-catenin rose markedly in response to Wnt3a, indicating Wnt/β-catenin signal transduction via regulation of GSK3-mediated phosphorylation (Figures 2a and c) . Contrastingly, in Dixdc1KO neurons there was no effect of Wnt3a treatment on active β-catenin level (Figures 2a and c) . Because GSK3 is independently regulated by the AKT pathway, we asked whether markers for this pathway were altered in Dixdc1KO versus WT neurons. In contrast to deficiencies observed in Wnt/β-catenin signal transduction, there were no differences in biochemical markers for the AKT pathway, including levels of phosphorylated AKT (p-AKT(Ser473)) or its specifically phosphorylated targets GSK3 (p-GSK3α(Ser21) and p-GSK3β(Ser9)) and β-catenin (p-β-cat(Ser522)) in Dixdc1KO neurons (Figure 2d ). The most universal transcriptional targets of the Wnt/β-catenin pathway are Axin2 and its molecular relative Axin1. We confirmed Wnt/β-catenin signal pathway disruption in Dixdc1KO neurons by directly measuring levels of these transcriptional targets using the quantitative reverse-transcriptase PCR. There was no difference in mRNA levels of Axin1 or Axin2 in unstimulated Dixdc1KO versus WT cultured forebrain neurons (Figures 2e-g) , demonstrating that these targets are basally transcribed normally in Dixdc1KO neurons. As expected, recombinant expression of a pointmutant-stabilized form of β-catenin (β-cat(S33Y)) that bypasses Wnt signal transduction increased Axin1 and Axin2 transcription in both Dixdc1KO and WT neurons with no effect on the control GAPDH (glyceraldehyde 3-phosphate dehydrogenase) transcript (Figures 2e-g) . In contrast, treatment with Wnt3a resulted in markedly different responses in Dixdc1KO versus WT neurons: levels of both target transcripts rose markedly in WT neurons, whereas this signaling response was greatly attenuated in Dixdc1KO neurons (Figures 2e and f) .
To determine whether dendritic spine and glutamatergic synapse phenotypes arise from decreased Wnt/β-catenin signaling efficiency in Dixdc1KO pyramidal neurons, we sought to rescue neurodevelopmental phenotypes by stimulating the pathway upstream and downstream of the putative pathway block. As anticipated, treatment with the upstream ligand Wnt3a had no or minimal effect on spine maturity and glutamatergic synapse density, although it did partially rescue spine density in Behavioral and neurodevelopmental phenotypes are rescued by lithium or GSK3 inhibitor Supporting a strong genotype-phenotype correlation between the Dixdc1KO allele and behavioral phenotypes in the Dixdc1KO mouse line, we noticed that behavioral differences on the FST, hyponeophagia assay and SIP were gene-dose sensitive, with heterozygous Dixdc1KO mice displaying an intermediate phenotype (Figures 1a, c and d, gray bars) . We hypothesized that this reflects Dixdc1-dose-sensitive reductions in Wnt/β-catenin signal transduction. To test this hypothesis, we asked whether these behavioral phenotypes could be corrected by treatment with the mood-stabilizing agent lithium chloride, which among other cell biological effects activates the Wnt/β-catenin pathway through direct inhibition of GSK3. 30 Indeed, systemic injection of either lithium chloride or a selective small-molecule GSK3 inhibitor (GSK3i) corrected behavioral phenotypes in Dixdc1KO animals, including in the FST (Figure 3a ) and SIP (Figure 3b ). Combined with reversible pharmacology (Supplementary Figure 4) , these data support that behavioral phenotypes in this animal model occur secondary to Dixdc1 gene-dose-sensitive changes in the regulation of GSK3, specifically increased GSK3 activity. We hypothesized that lithium/GSKi-responsive behavioral abnormalities in Dixdc1KO mice correspond to spine and glutamatergic synapse deficits and tested this by using a drug administration protocol identical to that which rescued behavior, assessing neurodevelopmental phenotypes instead. We found that both lithium and GSK3i rescued dendritic spine density, spine morphology and glutamatergic synapse density in L5/6 pyramidal neurons within these animals' brains (Figures 3c-k) .
Inherited rare missense DIXDC1 SNVs are more prevalent in psychiatric cases Given the preceding results, we asked whether sequence variation at the DIXDC1 locus, which encodes two major isoform classes ( Figure 4a ), 6,31 might contribute to psychiatric disorders. We first analyzed two data sets of exome sequences (Supplementary Figure 5 ), totaling nearly 6000 ASD cases and over 7000 controls, focusing on 'sequence-disrupting' single-nucleotide variants (SNVs) most likely to affect Dixdc1 function-that is, nonsense, missense and conserved splice-donor/acceptor-disrupting SNVs. This revealed a greater burden of rare sequence-disrupting SNVs at this locus in ASD versus unaffected controls (Figures 4b and c , left-most bars; Supplementary Figures 5a and b ).
Next, we analyzed a sample of~1000 BD patients and a similarly sized ethnically matched control cohort. There was once again a greater burden of rare sequence-disrupting SNVs in both isoforms in BD cases versus controls (Figures 4b and c , middle-left bars). Finally, we analyzed a data set of over 2500 exome sequences from Scz patients and a similar number of ethnically matched controls. 32 Here again, a greater burden of rare sequence-disrupting SNVs was present in cases versus controls (Figures 4b and c , middle-right bars).
In each psychiatric data set (2 ASD data sets, 1 BD data set and 1 Scz data set), there was a higher burden of rare sequencedisrupting SNVs in each of two major DIXDC1 isoforms in those affected, compared with those unaffected, by the disorder. Combining these data sets-totaling over 9000 cases and over 11 000 controls-there was a higher burden of rare sequencedisrupting SNVs for each isoform across these three psychiatric disorders; this association was greater for isoform 2 than for isoform 1 (isoform 1, P = 1.7 × 10 − 3 ; isoform 2, P = 2 × 10 − 4 ; Figures 4b and c , right-most bars; Supplementary Tables  2 and 3 ).
Rare missense SNVs from ASD patients alter Wnt/β-catenin signaling function
The two major DIXDC1 isoforms have distinct expression patterns, the longer isoform 1 has a relatively widespread embryonic tissue distribution, whereas the shorter isoform 2 predominates in the developing nervous system at later stages and in neurons of the mature brain. 6, 9, 33 Isoform 2 also has far more robust activity in standard cell-based Wnt/β-catenin signaling assays (Figure 4d ). 6 We accordingly tested rare missense SNVs in isoform 2 from our discovery data set (Figure 5a and Supplementary Table 3 , AASC) for functional effects on this pathway by engineering each SNV into a human DIXDC1 isoform 2 cDNA and testing signaling activity. 34 We found that, compared with WT, most of these SNVs either reduced or increased Wnt/β-catenin pathway activation by the encoded protein (Figure 5b ). Wnt/β-catenin pathway hyperactivating SNVs cause dominant spine and synapse deficits With allele frequencies ⩽ 0.1%, each of the SNVs we studied is present in a single copy in patients; to contribute to psychiatric pathogenesis they must therefore have a dose-dependent or dominant effect over the WT allele. To test for this, we assessed whether SNV-containing isoform 2 cDNAs caused dominant neurodevelopmental effects when recombinantly expressed in WT cultured hippocampal neurons. The WT human isoform 2 protein had no effect on spine density, spine maturity or glutamatergic synapse density when recombinantly expressed in WT neurons (Figures 5f-h Recent genomic and pharmacological studies suggest that the pathophysiology of ASD, Scz, BD and other psychiatric conditions overlaps and involves formation, maintenance, removal and function of spines and glutamatergic synapses. 1, 2, 4, [35] [36] [37] [38] [39] Our findings fit into this narrative, adding further evidence that abnormal spine and glutamatergic synapse density contributes to psychiatric pathogenesis. Our work provides a compelling case that Dixdc1 contributes to the formation, plasticity and/or maintenance of dendritic spines and glutamatergic synapses via facilitation of Wnt/β-catenin signal transduction within pyramidal neurons and that rare missense variants in DIXDC1 contribute to psychiatric susceptibility by decreasing or increasing Wnt pathway activity in these cells. This is consistent with evidence from largescale sequencing and other studies showing that loss-of-function mutations in either Wnt/β-catenin pathway inhibitors (e.g. CHD8, APC) 40, 41 or activators (e.g. CTTNβ1, WNT1) 4,42,43 contribute to susceptibility for ASD, as well as identifying differentiating cortical pyramidal neurons as a likely locus of cellular pathology in this disorder. 44 Nonetheless, we cannot rule out that additional biochemical mechanisms may contribute to these neurodevelopmental and behavioral outcomes. For example, a β-catenin-independent mechanism downstream of GSK3, such as one that regulates cytoskeletal proteins, 45 could also be important in mediating spine and synapse density. Dixdc1 isoforms have been implicated in other signaling cascades including LKB-MARK1/4, 46 PI3K-AKT/ AP1, [47] [48] [49] CKD5-DISC1-Ndel1, 7 JNK 50,51 and actin binding. 31 Our studies have focused on the late neurally enriched, Wnt/β-catenin pathway active isoform of DIXDC1 for which we found the most compelling genetic evidence for association with psychiatric disorders (Figures 4b and c) . It is plausible that genetic variants affecting more than one DIXDC1 isoform (Supplementary Tables 2   and 3 ) contribute to psychiatric susceptibility by disrupting multiple biological pathways. 7 Several different biochemical mechanisms have been proposed to underlie the anxiolytic, antidepressant and mood-stabilizing properties of lithium, a drug whose systematic use in modern psychiatry began in the first half of the last century. 52 Lithium's best-validated mechanisms of action are inhibitory effects on IMP and INPP1, central phosphatases in the phosphoinositide pathway and on GSK3, the central kinase in the Wnt/β-catenin and AKT pathways. 53 Our data showing that loss of Dixdc1 in mice leads to impaired neuronal Wnt/β-catenin signal-transduction and genedose-sensitive behavioral phenotypes rectified by lithium or a selective GSK3i support that GSK3 inhibition is a major contributor to lithium's therapeutic action. Moreover, in this mouse model the correlation between GSK3, behavior, dendritic spine and glutamatergic synapse phenotypes supports the notion that spines and glutamatergic synapses are critical biological substrates underlying lithium-responsive psychiatric conditions. [54] [55] [56] 
